Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miyauchi, J
Right arrow Articles by Mizutani, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyauchi, J
Right arrow Articles by Mizutani, S
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Mutations of the N-ras gene in juvenile chronic myelogenous leukemia

J Miyauchi, M Asada, M Sasaki, Y Tsunematsu, S Kojima and S Mizutani

Department of Virology, National Children's Medical Research Center, Tokyo, Japan.

Juvenile chronic myelogenous leukemia (JCML), a myeloproliferative disorder of childhood, is distinct from adult-type chronic myelogenous leukemia (CML) and bears resemblance to chronic myelomonocytic leukemia (CMMoL). Since mutations in the N-ras gene have been found at high frequencies in CMMoL, but only rarely in CML, we analyzed mutations activating the N-ras gene in 20 patients with JCML. We used the strategy for analysis of gene mutations based on in vitro DNA amplification by polymerase chain reaction (PCR) followed by single- strand conformation polymorphism (SSCP) analysis and/or direct sequence analysis. Nucleotide sequence analysis showed single nucleotide substitutions involving codons 12, 13, or 61 in six of 20 patients (30%). Four of six patients with mutations were in chronic phase and the other two in blast crisis, indicating no apparent correlation with disease stage. Most of the patients with mutations were in the older age group with poor prognosis, although one patient in the younger age group also harbored the mutation. These data suggest that N-ras gene mutations may be involved in the pathogenesis and/or prognosis of JCML and provide further evidence that JCML is an entity distinct from CML.

Volume 83, Issue 8, pp. 2248-2254, 04/15/1994
Copyright © 1994 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
L. Pearn, J. Fisher, A. K. Burnett, and R. L. Darley
The role of PKC and PDK1 in monocyte lineage specification by Ras
Blood, May 15, 2007; 109(10): 4461 - 4469.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. J. Chan and G.-S. Feng
PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase
Blood, February 1, 2007; 109(3): 862 - 867.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N. Omidvar, L. Pearn, A. K. Burnett, and R. L. Darley
Ral Is both Necessary and Sufficient for the Inhibition of Myeloid Differentiation Mediated by Ras
Mol. Cell. Biol., May 15, 2006; 26(10): 3966 - 3975.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Ohtsuka, A. Manabe, H. Kawasaki, D. Hasegawa, Y. Zaike, S. Watanabe, T. Tanizawa, T. Nakahata, and K. Tsuji
RAS-blocking bisphosphonate zoledronic acid inhibits the abnormal proliferation and differentiation of juvenile myelomonocytic leukemia cells in vitro
Blood, November 1, 2005; 106(9): 3134 - 3141.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Schubbert, K. Lieuw, S. L. Rowe, C. M. Lee, X. Li, M. L. Loh, D. W. Clapp, and K. M. Shannon
Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells
Blood, July 1, 2005; 106(1): 311 - 317.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. L. Loh, S. Vattikuti, S. Schubbert, M. G. Reynolds, E. Carlson, K. H. Lieuw, J. W. Cheng, C. M. Lee, D. Stokoe, J. M. Bonifas, et al.
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
Blood, March 15, 2004; 103(6): 2325 - 2331.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. O. Iversen, P. D. Emanuel, and M. Sioud
Targeting Raf-1 gene expression by a DNA enzyme inhibits juvenile myelomonocytic leukemia cell growth
Blood, May 13, 2002; 99(11): 4147 - 4153.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
R. J. Arceci, B. J. Longley, and P. D. Emanuel
Atypical Cellular Disorders
Hematology, January 1, 2002; 2002(1): 297 - 314.
[Abstract] [Full Text]


Home page
ASH Education BookHome page
F. R. Appelbaum, J. M. Rowe, J. Radich, and J. E. Dick
Acute Myeloid Leukemia
Hematology, January 1, 2001; 2001(1): 62 - 86.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. W. M. Reuter, M. A. Morgan, and L. Bergmann
Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?
Blood, September 1, 2000; 96(5): 1655 - 1669.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. D. Emanuel, R. C. Snyder, T. Wiley, B. Gopurala, and R. P. Castleberry
Inhibition of juvenile myelomonocytic leukemia cell growth in vitro by farnesyltransferase inhibitors
Blood, January 15, 2000; 95(2): 639 - 645.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Rebollo and C. Martinez-A
Ras Proteins: Recent Advances and New Functions
Blood, November 1, 1999; 94(9): 2971 - 2980.
[Full Text] [PDF]


Home page
Cancer Res.Home page
D. M. Beaupre, M. Talpaz, F. C. Marini III, R. J. Cristiano, J. A. Roth, Z. Estrov, M. Albitar, M. H. Freedman, and R. Kurzrock
Autocrine Interleukin-1{beta} Production in Leukemia: Evidence for the Involvement of Mutated RAS6
Cancer Res., June 1, 1999; 59(12): 2971 - 2980.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. M. Beaupre and R. Kurzrock
RAS and Leukemia: From Basic Mechanisms to Gene-Directed Therapy
J. Clin. Oncol., March 1, 1999; 17(3): 1071 - 1071.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Luna-Fineman, K. M. Shannon, S. K. Atwater, J. Davis, M. Masterson, J. Ortega, J. Sanders, P. Steinherz, V. Weinberg, and B. J. Lange
Myelodysplastic and Myeloproliferative Disorders of Childhood: A Study of 167 Patients
Blood, January 15, 1999; 93(2): 459 - 466.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. O. Iversen and M. Sioud
Modulation of Granulocyte-Macrophage Colony-Stimulating Factor Gene Expression by a Tumor Necrosis Factor alpha Specific Ribozyme in Juvenile Myelomonocytic Leukemic Cells
Blood, December 1, 1998; 92(11): 4263 - 4268.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. O. Iversen, I. D. Lewis, S. Turczynowicz, H. Hasle, C. Niemeyer, K. Schmiegelow, S. Bastiras, A. Biondi, T. P. Hughes, and A. F. Lopez
Inhibition of Granulocyte-Macrophage Colony-Stimulating Factor Prevents Dissemination and Induces Remission of Juvenile Myelomonocytic Leukemia in Engrafted Immunodeficient Mice
Blood, December 15, 1997; 90(12): 4910 - 4917.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Arico, A. Biondi, and C.-H. Pui
Juvenile Myelomonocytic Leukemia
Blood, July 15, 1997; 90(2): 479 - 488.
[Full Text] [PDF]


Home page
BloodHome page
C.M. Niemeyer, M. Arico, G. Basso, A. Biondi, A. C. Rajnoldi, U. Creutzig, O. Haas, J. Harbott, H. Hasle, G. Kerndrup, et al.
Chronic Myelomonocytic Leukemia in Childhood: A Retrospective Analysis of 110 Cases
Blood, May 15, 1997; 89(10): 3534 - 3543.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1994 by American Society of Hematology         Online ISSN: 1528-0020